Skip to main content
Clinical Trials/CTRI/2023/10/059333
CTRI/2023/10/059333
Not yet recruiting
未知

Evaluation of Neutrophil to Lymphocyte (NLR),Platelet to lymphocyte (PLR) and Lymphocyte to Monocyte (LMR) ratios in peripheral blood of patients having periodontitis with type 2 diabetes mellitus before and one month after scaling and root planing - NI

Dr. Nikita Vikasrao Palkar0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr. Nikita Vikasrao Palkar
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Dr. Nikita Vikasrao Palkar

Eligibility Criteria

Inclusion Criteria

  • 1\.Subjects with clinically healthy periodontium, with no attachment loss and probing depth of less than or equal to 3 mm, \<10%bleeding sites, subject with gingival index score of maximum up to \<1, included which were considered to be relatively healthy and subject having HbA1c level between 4%–6% considered as control group.
  • 2\.Group B:
  • 1\.Patients with Periodontitis stage II and stage III as per the 2017 American Academy of Periodontology Classification.
  • 2\.Patients with periodontitis stage II having clinical attachment loss of 3\-4mm and maximum probing pocket depth \=5 mm.
  • 3\.Patients with periodontitis stage III having clinical attachment loss of \=5 mm and maximum probing pocket depth \= 6mm.35
  • 3\.Group C:
  • 1\.Patients with periodontitis (stage II and stage III as per the 2017 American Academy of Periodontology classification) with diagnosed case of type 2 diabetes mellitus (Good diabetes control, HbA1c level 7%)

Exclusion Criteria

  • 1\.Patient refusal
  • 2\.Patient who has received periodontal treatment in last 6months.
  • 3\.Patient who is smoker or consuming any other form of tobacco.
  • 4\.Pregnant, lactating or postmenopausal women.
  • 5\.Hospitalized patients.
  • 6\.Subjects consuming antibiotic or other drugs in the past 6 months that affect their periodontal status.
  • 7\.History of any systemic disease which influences the values of NLR, PLR, and LMR ratio like any malignancy, cardiovascular diseases, rheumatic diseases, bipolar disorder, thyrotoxicosis, psoriasis other than type 2 diabetes mellitus for the test group (Group III)
  • 8\.History of any systemic disease for the control group.
  • 9\.If subject cannot maintain oral hygiene after non\-surgical periodontal therapy (Gingival index score \>1, plaque index \>1\).

Outcomes

Primary Outcomes

Not specified

Similar Trials